Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?

The CERERRA database provides evidence that low-dose rituximab performs as well as the conventional dose in the real world, thus highlighting the possible pharmacoeconomic impact. In clinical trials, it has be...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Source Type: research